CRWV insider filing: 250K founders' shares proposed sale via Morgan Stanley

Rhea-AI Filing Summary

Form 144 filed for CoreWeave, Inc. (CRWV) reports a proposed sale of 250,000 common shares through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $33,307,500, with an approximate sale date of 09/23/2025 on NASDAQ. The filing shows these shares were acquired as Founders Shares on 11/13/2017. The notice lists multiple prior Rule 10b5-1 sales by Brannin McBee and the Brannin J. McBee 2022 IRR Trust between 08/19/2025 and 09/16/2025, each entry showing identical paired blocks of 250,000 and 375,000 shares sold on several dates with reported gross proceeds for each sale. The filer represents there is no undisclosed material adverse information and references reliance on trading plans where applicable.

Positive

• Planned sale fully disclosed with broker, share count, market value, and proposed sale date
• Origin of shares documented as Founders Shares acquired on 11/13/2017
• Multiple prior 10b5-1 sales listed with dates, amounts, and gross proceeds providing transparent transaction history

Negative

• Large insider dispositions are recorded, including a proposed sale valued at $33,307,500
• Repeated 10b5-1 sales by the same individuals/trust between 08/19/2025 and 09/16/2025 indicating notable insider liquidity

Insights

Financial Analyst

TL;DR: Multiple scheduled insider sales reported; proposed 250,000-share sale valued at $33.3M is disclosed under Rule 144.

The filing documents a planned sale of 250,000 shares by an insider using Morgan Stanley as broker and confirms those shares were founders shares acquired on 11/13/2017. It also enumerates a series of Rule 10b5-1 sales by Brannin McBee and an affiliated trust from 08/19/2025 through 09/16/2025 with explicit amounts and gross proceeds reported. For analysts this is a clear, routine disclosure of insider liquidity activity rather than financial performance data; it provides transaction dates, volumes, and gross proceeds that can be used to track insider disposition but does not include operating metrics or valuation context.

Corporate Governance Expert

TL;DR: Documented compliance with Rule 144 and 10b5-1 procedures; multiple scheduled dispositions are disclosed.

The submission contains the required statements certifying no undisclosed material adverse information and records the dates of adoption or instruction where 10b5-1 plans apply. The filing satisfies disclosure obligations for proposed insider sales and lists broker information. It does not indicate any regulatory exception or dispute, but it does show notable insider liquidity events which stakeholders may examine for timing and governance implications. No additional corporate governance actions or departures are reported in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	250000	33307500.00	370470348	09/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			250000	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/16/2025	250000	29542575.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/16/2025	375000	44313862.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/09/2025	250000	24866825.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/09/2025	375000	37301250.00
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	250000	23292325.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	09/02/2025	375000	34938487.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	250000	22996925.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/26/2025	375000	34495387.50
10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	250000	22926475.00
10b5-1 Sales for BRANNIN J. MCBEE 2022 IRR TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/19/2025	375000	34389712.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CoreWeave (CRWV) report?

The form reports a proposed sale of 250,000 common shares via Morgan Stanley with an aggregate market value of $33,307,500 and an approximate sale date of 09/23/2025.

When were the shares to be sold originally acquired?

The shares were acquired as Founders Shares on 11/13/2017 according to the filing.

Are there recent insider sales disclosed in the filing?

Yes. The filing lists multiple Rule 10b5-1 sales by Brannin McBee and the Brannin J. McBee 2022 IRR Trust between 08/19/2025 and 09/16/2025 with specific amounts and gross proceeds for each trade.

Which broker is handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza.

Does the filer confirm no undisclosed material information?

Yes. By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.